DLD Asset Management LP bought a new stake in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 60,000 shares of the company’s stock, valued at approximately $644,000. DLD Asset Management LP owned 0.17% of M3-Brigade Acquisition V at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Saba Capital Management L.P. acquired a new position in shares of M3-Brigade Acquisition V in the fourth quarter valued at about $151,000. Hudson Bay Capital Management LP purchased a new position in shares of M3-Brigade Acquisition V in the fourth quarter worth about $159,000. Prelude Capital Management LLC acquired a new stake in shares of M3-Brigade Acquisition V during the third quarter worth about $281,000. Sandia Investment Management LP purchased a new stake in M3-Brigade Acquisition V in the second quarter valued at approximately $334,000. Finally, Susquehanna International Group LLP purchased a new stake in M3-Brigade Acquisition V in the third quarter valued at approximately $586,000.
M3-Brigade Acquisition V Stock Down 3.4%
NASDAQ:MBAV opened at $10.77 on Thursday. The company has a 50 day moving average price of $10.81 and a 200-day moving average price of $10.76. M3-Brigade Acquisition V Corp. has a 1-year low of $9.10 and a 1-year high of $11.96.
Analysts Set New Price Targets
Several brokerages recently weighed in on MBAV. Wall Street Zen upgraded shares of M3-Brigade Acquisition V to a “sell” rating in a report on Saturday, June 27th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of M3-Brigade Acquisition V in a report on Wednesday, June 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.
Check Out Our Latest Stock Report on MBAV
M3-Brigade Acquisition V Profile
M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.
The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.
See Also
- Five stocks we like better than M3-Brigade Acquisition V
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding MBAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Free Report).
Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.
